Related Experiment Video
Updated: May 9, 2026

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5
Published on: November 13, 2015
Generation of human cardiomyocytes for cardiac regenerative therapies: differentiation and direct reprogramming
Chani Hodonsky, Kaihong Wu, Lakshmi Mundada
1Department of Cardiac Surgery, 11-735 C.S. Mott Children's Hospital, University of Michigan, 1540 E. Hospital Drive, SPC 4204, Ann Arbor, Michigan 48109-4204. mingsing@med.umich.edu.
Abstract:
The generation of functional human cardiomyocytes carries the potential of replacing damaged, malformed, or congenitally absent cardiac tissue as a definitive cure for cardiac disease. Furthermore, patient-specific cardiomyocytes may yield useful in vitro models of heart tissue for disease investigation, drug development and personalized therapy evaluation. This field has experienced rapid advances in the past few years. Nearly pure populations of cardiomyocytes have been generated from human pluripotent stem cells and new strategies to generate cardiomyocytes from somatic cells have been introduced. Here we review the latest breakthroughs in cardiomyocyte differentiation from human pluripotent stem cells and the creation of cardiomyocytes by direct reprogramming strategies, as well as discuss their limitations.
More Related Videos
Related Concept Videos
Somatic to iPS Cell Reprogramming
iPS Cell Differentiation

